Colin Kaepernick is currently without an NFL team to call home, but is his fate self-inflicted? / REUTERS

Is Kaepernick's Fate Self-Inflicted

Three months into NFL free-agency, the silent elephant in room has now begun to stampede Colin Kaepernick, considered by some to be one of the league’s most eligible quarterbacks, still has not been signed.

It’s not unheard of for prominent players to find themselves in NFL limbo, but this predicament has been generating hefty buzz considering it was only four years ago that the former San Francisco 49ers’ quarterback helped lead his team to Super Bowl XLVII against the Baltimore Ravens.

Back then he ran for a quarterback playoff-record of 181 yards and two touchdowns against Green Bay as the 49ers beat thePackersin a divisional playoff game. Today, he waits for a phone call confirming a spot on a team.

Though given his political stance over the past year, including kneeling during the national anthem, some might not be surprised.

Back in March, an anonymous AFC general manager spoke with the Bleacher Report about the politically enthused free agent’s chances of getting picked up by a team, despite his ability to “still play at a high level.”

“The problem is three things are happening with him,” he said. “First, some teams genuinely believe that he can’t play. They think he’s shot. I’d put that number around 20 percent.”

“Second, some teams fear the backlash from fans after getting him. They think there might be protests or [President Donald] Trump will tweet about the team. I’d say that number is around 10 percent. Then there’s another 10 percent that has a mix of those feelings,” he continued.

“Third, the rest genuinely hate him and can’t stand what he did. They want nothing to do with him. They won’t move on. They think showing no interest is a form of punishment. I think some teams also want to use Kaepernick as a cautionary tale to stop other players in the future from doing what he did.”

With the pre-season fast approaching, Scott Ostler at the San Francisco Chronicle recently wrote about Kaepernick’s troubles by summarizing it up as him being “simply lousy at groveling.”

The sports columnist even compared the athlete to Marvin Gaye by writing, “Kaepernick is like Marvin Gaye, a stubborn kind of fella.”

Aside from taking playful jabs, Ostler however did take a career advice approach by wondering why Kaepernick won’t take the recommended steps that have been given to him to assure a league position.

For instance, Ostler cited remarks by John Lynch, the 49ers’ new general manager, who told sports radio station KNBR that he suggested to Kaepernick, as the team was cutting ties, that he make an effort to convey to the NFL that he still has a great desire to play football.

“He makes a compelling case as to how bad he wants to be in the league when you talk to him … and I think that would help him,” Lynch said he told Kaepernick, adding he also suggested he sit down for a public interview.

Ostler raised a bigger question pondering about what politics really have to do with football in the first place and at what point it should take a toll on one’s career.

“Tom Brady rocked a Trump ball cap, and nobody is calling for his job,” he joked.

One thing is for sure, with four weeks away from the start of NFL pre-season, whether Kaepernick finds himself on a 53-man roster or not, he won’t be begging for it.

Latest News

What Friends Tell Friends: Choose Kaiser Permanente

Originally published on Integrated, nonprofit health plan tops NICE Satmetrix customer experience benchmark study for 10th straight year. For the 10th year in a row, more people would recommend Kaiser Permanente to a friend or colleague than any other health plan in the nation, according to the recently released…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Mastercard Expands to the U.S. & Canada, Delivering a Search Tool That Identifies What Stores Near You Are Open for Business

Originally published on Search solution complements new Digital Acceleration for Small Business global initiative which helps small businesses advance digitally and drive online commerce As businesses seek to draw customers back both in store and online, Mastercard is introducing new tools to support them. Today, Mastercard announced the geographic…

TIAA Launches Programs to Raise Awareness of Racial Injustice and Support Communities in Need through the “Be The Change” Initiative

On June 30, TIAA announced new virtual programs designed to raise awareness of racial injustice and support communities in need as a part of the company’s recently launched “Be the Change” initiative. One is TIAA’s “Race Against Racism,” an effort in support of The Innocence Project which included more than…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….